REDDY-DASATINIB

dr reddy's laboratories ltd🇨🇦 Health Canada

Approval Id: 5bea30f494df5a24
Drug Approval Canada Name: REDDY-DASATINIB
Product Name: REDDY-DASATINIB
Status: Marketed
Status Date: 2021-09-16
Original Market Date: 2021-09-16
Din: 02514761
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EA02 DASATINIB
Atc Name: l 01 ea 02
Aig Number: 0152198005
Company Name: dr reddy's laboratories ltd
Company Address: Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090

DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5bea30f494df5a24

Type

Standard